OTCPK:CLIF.F

Stock Analysis Report

Executive Summary

Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, Indonesia, Myanmar, Vietnam, the Philippines, and internationally.

Snowflake

Fundamentals

Flawless balance sheet with acceptable track record.

Risks

  • Cordlife Group is not covered by any analysts.

Share Price & News

How has Cordlife Group's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

OTCPK:CLIF.F

-1.2%

US Healthcare

-0.02%

US Market


1 Year Return

n/a

OTCPK:CLIF.F

-9.4%

US Healthcare

1.6%

US Market

No trading data on CLIF.F.

No trading data on CLIF.F.


Share holder returns

CLIF.FIndustryMarket
7 Day0%-1.2%-0.02%
30 Day0%-2.2%2.7%
90 Day0%-1.5%1.4%
1 Yearn/a-8.0%-9.4%3.8%1.6%
3 Year-60.2%-60.2%28.7%23.5%45.2%35.8%
5 Year-61.1%-61.1%62.7%53.0%61.8%44.1%

Price Volatility Vs. Market

How volatile is Cordlife Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Cordlife Group undervalued based on future cash flows and its price relative to the stock market?

28.15x

Price to Earnings (PE) ratio


Intrinsic Value Based on Future Cash Flows

Cordlife Group's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).

Cordlife Group's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).


Price Based on Earnings

Cordlife Group is overvalued based on earnings compared to the US Healthcare industry average.

Cordlife Group is overvalued based on earnings compared to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Cordlife Group, we can't assess if its growth is good value.


Price Based on Value of Assets

Cordlife Group is good value based on assets compared to the US Healthcare industry average.


Next Steps

Future Growth

How is Cordlife Group expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

27.8%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Unable to determine if Cordlife Group is high growth as no revenue estimate data is available.

Cordlife Group's earnings are expected to grow significantly at over 20% yearly.

Unable to compare Cordlife Group's revenue growth to the United States of America market average as no estimate data is available.

Cordlife Group's earnings growth is expected to exceed the United States of America market average.

Cordlife Group's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if Cordlife Group will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has Cordlife Group performed over the past 5 years?

-46.8%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Cordlife Group's year on year earnings growth rate was negative over the past 5 years and the most recent earnings are below average.

Cordlife Group's 1-year earnings growth exceeds its 5-year average (25.2% vs -46.8%)

Cordlife Group's earnings growth has exceeded the US Healthcare industry average in the past year (25.2% vs 5.6%).


Return on Equity

Cordlife Group has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).


Return on Assets

Cordlife Group used its assets less efficiently than the US Healthcare industry average last year based on Return on Assets.


Return on Capital Employed

Cordlife Group has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is Cordlife Group's financial position?


Financial Position Analysis

Cordlife Group is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Cordlife Group's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Cordlife Group's level of debt (3.8%) compared to net worth is satisfactory (less than 40%).

The level of debt compared to net worth has been reduced over the past 5 years (9.1% vs 3.8% today).

Debt is well covered by operating cash flow (116.3%, greater than 20% of total debt).

Cordlife Group earns more interest than it pays, coverage of interest payments is not a concern.


Balance Sheet

Low level of unsold assets.

Debt is covered by short term assets, assets are 19.1x debt.


Next Steps

Dividend

What is Cordlife Group's current dividend yield, its reliability and sustainability?

1.76%

Current Dividend Yield


Dividend Yield and Payments Analysis

Cordlife Group's pays a higher dividend yield than the bottom 25% of dividend payers in United States of America (1.46%).

Cordlife Group's dividend is below the markets top 25% of dividend payers in United States of America (3.72%).

Cordlife Group has been paying a dividend for less than 10 years and during this time payments have been volatile (annual drop of over 20%).

Cordlife Group has only been paying a dividend for 7 years, and since then dividends per share have fallen.


Current Payout to Shareholders

Dividends paid are well covered by earnings (2x coverage).


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Cordlife Group's salary, the management and board of directors tenure and is there insider trading?

2.6yrs

Average management tenure


CEO

Poh Tan (57yo)

0.6yrs

Tenure

0

Ms. Poh Lan Tan has been Group Chief Executive Officer and Executive Director at Cordlife Group Limited since February 28, 2019 and served as its Group Chief Operating Officer since April 12, 2016 until 20 ...


Management Age and Tenure

2.6yrs

Average Tenure

43yo

Average Age

The tenure for the Cordlife Group management team is about average.


Board Age and Tenure

1.4yrs

Average Tenure

56yo

Average Age

The average tenure for the Cordlife Group board of directors is less than 3 years, this suggests a new board.


Insider Trading

More shares have been bought than sold by Cordlife Group individual insiders in the past 3 months.


Recent Insider Transactions

SellS$6,526,82112 Jul 19
FIL Limited
EntityCompany
Shares16,880,000
Max PriceS$0.39
BuyS$7,459,22111 Jul 19
Kwok Lung Hon
EntityIndividual
Shares16,880,000
Max PriceS$0.44
BuyS$17,811,95316 Nov 18
Kwok Lung Hon
EntityIndividual
Shares54,580,300
Max PriceS$0.33

Ownership Breakdown


Management Team

  • Poh Tan (57yo)

    Group CEO & Executive Director

    • Tenure: 0.6yrs
  • Hnin Thet (43yo)

    Group Finance Director

    • Tenure: 2.6yrs
  • Siew Koon Ang

    Company Secretary

    • Tenure: 0yrs
  • Huiying Tan (37yo)

    Group Director of Quality & Operations

    • Tenure: 5.2yrs
  • Andrew Ekaputra

    Group Technical Director

    • Tenure: 0yrs
  • Boon Yong Choo

    Group Chief Financial Officer

    • Tenure: 2.6yrs

Board Members

  • Chi Wah Fong (56yo)

    Non-Independent Non-Executive Director

    • Tenure: 0.7yrs
  • Poh Tan (57yo)

    Group CEO & Executive Director

    • Tenure: 0.6yrs
  • Choon Hou Ho (47yo)

    Vice Chairman

    • Tenure: 2.8yrs
    • Compensation: S$150.00k
  • Jin Hian Goh (50yo)

    Chairman

    • Tenure: 1.4yrs
    • Compensation: S$124.50k
  • Joseph Wong (64yo)

    Independent Director

    • Tenure: 5yrs
    • Compensation: S$124.50k
  • Jiangyong Bu (43yo)

    Non-Independent Non-Executive Director

    • Tenure: 1.3yrs
  • Christine Wong

    Non-Independent Non-Executive Director

    • Tenure: 2.8yrs
  • Tongyan Wang

    Non-Independent Non-Executive Director

    • Tenure: 2.3yrs
  • Hwee Yeo (62yo)

    Independent Director

    • Tenure: 1.3yrs
    • Compensation: S$50.82k

Company Information

Cordlife Group Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Cordlife Group Limited
  • Ticker: CLIF.F
  • Exchange: OTCPK
  • Founded: 2001
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: S$115.424m
  • Listing Market Cap: S$83.655m
  • Shares outstanding: 253.68m
  • Website: https://www.cordlife.com

Number of Employees


Location

  • Cordlife Group Limited
  • A’Posh Bizhub
  • No. 06-01 / 09, 1 Yishun Industrial Street 1
  • Singapore
  • 768160
  • Singapore

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
P8ASGX (Singapore Exchange)YesOrdinary SharesSGSGDMar 2012
3DCBST (Boerse-Stuttgart)YesOrdinary SharesDEEURMar 2012
CLIF.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDMar 2012

Biography

Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, Indonesia, Myanmar, Vietnam, the Philippines, and internationally. It o ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/12 00:20
End of Day Share Price2019/06/14 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.